CTOs on the Move

Rubius Therapeutics

www.rubiustx.com

 
Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.rubiustx.com
  • 399 Binney Street Suite 300
    Cambridge, MA USA 02139
  • Phone: 617.679.9600

Executives

Name Title Contact Details

Funding

Rubius Therapeutics raised $25M on 12/09/2015
Rubius Therapeutics raised $120M on 06/21/2017
Rubius Therapeutics raised $100M on 02/28/2018
Rubius Therapeutics raised $200M on 03/17/2021

Similar Companies

Indevus Pharmaceuticals

Indevus Pharmaceuticals Inc. is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zuni Technologies Inc

Zuni Technologies Inc is a Zuni, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emalex Biosciences

Developing new treatments for rare and orphan neurological conditions.

Innovate Biopharmaceuticals

Innovate is a clinical stage biotechnology company developing novel medicines for gastroenterological disorders.

CoMentis

CoMentis is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.